Related Experiment Video
Updated: May 7, 2026

A Tandem Liquid Chromatography–Mass Spectrometry-based Approach for Metabolite Analysis of Staphylococcus aureus
Published on: March 28, 2017
Activity-Based Protein Profiling Identifies an α-Amylase Family Protein Contributing to the Virulence of
Md Jalal Uddin1, Kjersti Julin1, Herman S Overkleeft2
1Centre for New Antibacterial Strategies (CANS) and Research Group for Host-Microbe Interactions, Department of Medical Biology (IMB), UiT─The Arctic University of Norway, 9019 Tromsø, Norway.
Abstract:
In search of new putative antimicrobial drug targets in methicillin-resistant Staphylococcus aureus, we aimed to identify and characterize retaining glycosidase activities in this bacterial pathogen. Using activity-based protein profiling (ABPP), a panel of 7 fluorescent probes was screened to detect activities of diverse retaining glycosidase families. Based on this, a cocktail of 3 biotinylated probes (targeting α-glucosidases, β-galactosidases and α-fucosidases) was used for target enrichment and three glycoside hydrolase family proteins were identified by mass-spectrometry: 6-phospho-β-glucosidase (BglA), α-amylase family protein trehalase C (TreC), and autolysin (Atl). The physiological relevance of previously uncharacterized BglA and TreC was addressed in CRISPRi and inhibitor studies with the putative TreC inhibitor α-cyclophellitol-aziridine. Silencing of treC did not affect bacterial growth in rich media, but reduced biofilm formation in vitro, and attenuated virulence during Galleria mellonella infection, warranting future investigations into the biochemical function of this enzyme.
Insights
Researchers identified novel antimicrobial drug targets in methicillin-resistant Staphylococcus aureus by characterizing retaining glycosidase activities. Trehalase C (TreC) showed potential, reducing biofilm formation and virulence in preliminary studies.
Area of Science:
- Microbiology
- Biochemistry
- Drug Discovery
Background:
- Methicillin-resistant Staphylococcus aureus (MRSA) poses a significant public health threat, necessitating novel antimicrobial strategies.
- Identifying essential bacterial enzymes can reveal new drug targets for combating antibiotic resistance.
Purpose of the Study:
- To identify and characterize retaining glycosidase activities in MRSA as potential antimicrobial drug targets.
- To investigate the roles of novel identified glycosidases, specifically BglA and TreC, in bacterial physiology and virulence.
Main Methods:
- Activity-based protein profiling (ABPP) using fluorescent and biotinylated probes to detect and enrich glycosidase activities.
- Mass spectrometry for identification of enriched glycoside hydrolase family proteins.
- CRISPR interference (CRISPRi) and inhibitor studies to assess the physiological relevance of identified enzymes.
Main Results:
- Three glycoside hydrolase family proteins were identified: 6-phospho-β-glucosidase (BglA), trehalase C (TreC), and autolysin (Atl).
- Silencing of treC in MRSA reduced in vitro biofilm formation and attenuated virulence in a Galleria mellonella infection model.
- BglA and TreC were identified as previously uncharacterized enzymes with potential roles in MRSA pathogenesis.
Conclusions:
- Retaining glycosidases represent a promising area for discovering new antimicrobial drug targets against MRSA.
- TreC warrants further investigation for its biochemical function and potential as a therapeutic target due to its impact on biofilm formation and virulence.
More Related Videos
Related Concept Videos
Antimicrobial Proteins
Interferons
Interferons (IFNs) are proteins produced by lymphocytes, macrophages, and fibroblasts infected with viruses. While IFNs cannot prevent viruses from entering and...
Staphylococcal Skin Infections
Mechanism of Antibiotic Resistance in MRSA
Clinical Significance of Antibiotic Resistance

